Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Application | Utility: (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS Filling date: 6 Nov 2025 Issue date: 17 Oct 2019 |
Application | Utility: SELECTIVE NR2B ANTAGONISTS Filling date: 6 Nov 2025 Issue date: 17 Oct 2019 |
Application | Utility: ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS Filling date: 6 Nov 2025 Issue date: 17 Oct 2019 |
Application | Utility: ANTIBODIES AGAINST MICA AND/OR MICB AND USES THEREOF Filling date: 6 Nov 2025 Issue date: 17 Oct 2019 |
Application | Utility: GSK-3 INHIBITORS Filling date: 6 Nov 2025 Issue date: 17 Oct 2019 |
Application | Utility: METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Nov 2025 Issue date: 17 Oct 2019 |
Application | Utility: TRICYCLIC HETEROARYL-SUBSTITUTED QUINOLINE AND AZAQUINOLINE COMPOUNDS AS PAR4 INHIBITORS Filling date: 6 Nov 2025 Issue date: 17 Oct 2019 |
Grant | Utility: Serum albumin-binding fibronectin type III domains Filling date: 6 Nov 2025 Issue date: 15 Oct 2019 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD DOMAIN PROTEINS THAT BIND TO MYOSTATIN Filling date: 6 Nov 2025 Issue date: 10 Oct 2019 |
Application | Utility: 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS Filling date: 6 Nov 2025 Issue date: 10 Oct 2019 |
Grant | Utility: Substituted tetrahydrocarbazole and carbazole carboxamide compounds Filling date: 6 Nov 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Tricyclic sulfones as ROR gamma modulators Filling date: 6 Nov 2025 Issue date: 8 Oct 2019 |
Grant | Utility: Method of using antibody polypeptides that antagonize CD40 to treat IBD Filling date: 6 Nov 2025 Issue date: 8 Oct 2019 |
Application | Utility: ANTI-TREM-1 ANTIBODIES AND USES THEREOF Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Application | Utility: CONTROL OF CELL GROWTH THROUGH A TEMPERATURE FEEDBACK LOOP Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Application | Utility: INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Application | Utility: ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Application | Utility: HETEROCYCLIC SULFONES AS ROR GAMMA MODULATORS Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Application | Utility: BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Application | Utility: SPIRO-FUSED CYCLIC UREAS AS INHIBITORS OF ROCK Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Application | Utility: LACTAM, CYCLIC UREA AND CARBAMATE, AND TRIAZOLONE DERIVATIVES AS POTENT AND SELECTIVE ROCK INHIBITORS Filling date: 6 Nov 2025 Issue date: 3 Oct 2019 |
Grant | Utility: Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation Filling date: 6 Nov 2025 Issue date: 1 Oct 2019 |
Grant | Utility: Treatment of hematologic malignancies with an anti-CXCR4 antibody Filling date: 6 Nov 2025 Issue date: 1 Oct 2019 |
Application | Utility: TGF Beta RECEPTOR ANTAGONISTS Filling date: 6 Nov 2025 Issue date: 26 Sep 2019 |
Application | Utility: ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATMENT OF RECURRENT SMALL CELL LUNG CANCER Filling date: 6 Nov 2025 Issue date: 26 Sep 2019 |
Application | Utility: TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY Filling date: 6 Nov 2025 Issue date: 26 Sep 2019 |
Application | Utility: HETEROARYL SUBSTITUTED AMINOPYRIDINE COMPOUNDS Filling date: 6 Nov 2025 Issue date: 26 Sep 2019 |
Application | Utility: RADIOLIGANDS FOR IMAGING THE IDO1 ENZYME Filling date: 6 Nov 2025 Issue date: 19 Sep 2019 |
Application | Utility: COMBINATION THERAPY WITH ANTI-CD73 ANTIBODIES Filling date: 6 Nov 2025 Issue date: 19 Sep 2019 |
Application | Utility: CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF Filling date: 6 Nov 2025 Issue date: 12 Sep 2019 |
Application | Utility: TRICYCLIC RHO KINASE INHIBITORS Filling date: 6 Nov 2025 Issue date: 12 Sep 2019 |
Application | Utility: GSK-3 INHIBITORS Filling date: 6 Nov 2025 Issue date: 12 Sep 2019 |
Grant | Utility: Fibronectin based scaffold domain proteins that bind to myostatin Filling date: 6 Nov 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Triazolopyridine inhibitors of myeloperoxidase Filling date: 6 Nov 2025 Issue date: 10 Sep 2019 |
Grant | Utility: Polypeptides targeting HIV fusion Filling date: 6 Nov 2025 Issue date: 10 Sep 2019 |
Grant | Utility: PD-L1 binding polypeptides for imaging Filling date: 6 Nov 2025 Issue date: 10 Sep 2019 |
Application | Utility: PHENYLPYRROLIDINONE FORMYL PEPTIDE 2 RECEPTOR AGONISTS Filling date: 6 Nov 2025 Issue date: 5 Sep 2019 |
Application | Utility: CYCLOBUTANE- AND AZETIDINE-CONTAINING MONO AND SPIROCYCLIC COMPOUNDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Nov 2025 Issue date: 5 Sep 2019 |
Grant | Utility: Antiproliferative compounds and conjugates made therefrom Filling date: 6 Nov 2025 Issue date: 3 Sep 2019 |
Grant | Utility: B7-related nucleic acids and polypeptides useful for immunomodulation Filling date: 6 Nov 2025 Issue date: 3 Sep 2019 |
Grant | Utility: TGF beta receptor antagonists Filling date: 6 Nov 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Filling date: 6 Nov 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer Filling date: 6 Nov 2025 Issue date: 3 Sep 2019 |
Grant | Utility: Injection aid for use with an injection device and method of use Filling date: 6 Nov 2025 Issue date: 3 Sep 2019 |
Application | Utility: 4-HYDROXY-3-(HETEROARYL)PYRIDINE-2-ONE APJ AGONISTS Filling date: 6 Nov 2025 Issue date: 29 Aug 2019 |
Application | Utility: TETRAZOLONE-SUBSTITUTED DIHYDROPYRIDINONE MGAT2 INHIBITORS Filling date: 6 Nov 2025 Issue date: 29 Aug 2019 |
Application | Utility: TREATMENT OF RENAL CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND ANOTHER ANTI-CANCER AGENT Filling date: 6 Nov 2025 Issue date: 29 Aug 2019 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD PROTEINS HAVING IMPROVED STABILITY Filling date: 6 Nov 2025 Issue date: 29 Aug 2019 |
Application | Utility: 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS Filling date: 6 Nov 2025 Issue date: 29 Aug 2019 |
Application | Utility: PYRIDYL SUBSTITUTED INDOLE COMPOUNDS Filling date: 6 Nov 2025 Issue date: 29 Aug 2019 |
Showing 700 to 750 of 772 patents.